Back to Industries & Applications
Overview
New classes of drugs are offering the healthcare industry the promise of improved outcomes for patients. These include pharmaceuticals and biologics, such as peptides, proteins and DNA-based treatments – all of which provide alternatives to traditional drugs. However, to be effective these new drugs typically cannot be administered by conventional means. Manufacturers are looking to new technologies to help provide effective drug delivery solutions.
The widespread adoption of smartphones is challenging the established relationship with healthcare providers and treatments. Patients expect that technology will allow them to receive treatment while still enjoying the freedom to carry on their daily lives. As security of data becomes more and more difficult, patients are also keen to protect their own personal information. Wireless connection of remote medical devices raises concerns about the dangers of data breaches. For patients that depend on drug delivery systems, protecting their privacy against hacking is key to establishing confidence in new drug delivery solutions.
Conventional approaches to medical regulation may act as an impediment to digital innovation in healthcare. The approval process is unlike that of consumer devices, with the need for testing and compliance with extensive medical regulation resulting in time-consuming research and development that is very expensive. Designers need to work with companies who can support the extended timescales involved in the regulatory process.
Despite these challenges, the benefits of this new technology are being felt by both patients and the healthcare industry. Receiving full medical care in the comfort of a patient’s own home lessens the time needed for their recovery and reduces the need for expensive hospital beds. To make these new drug delivery solutions a reality, Phillips-Medisize, a Molex Company, brings decades of expertise to help manufacturers navigate the complex regulatory environment while providing rapid innovation and the flexibility to deliver efficient product launches on a global scale.
By the Numbers
USD 1.43 Billion
Drug Delivery Market
1.1 Billion
Wearable Devices Sold
20%
Medtech Spend Growth
Featured Resources
Featured Videos
In this insightful and informative webchat Mike Deppe, Vice President & General Manager at Molex discusses relevant trends and opportunities driving new solutions for Medical Wearables applications. Watch this lively, interactive, 5-minute dialogue regarding Molex capabilities for the Medical Wearables industry.
Designing Medical Wearables for Real-Life